{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:55:59Z","timestamp":1792605359048,"version":"4.5.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T00:00:00Z","timestamp":1363132800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0058204","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T18:55:41Z","timestamp":1363200941000},"page":"e58204","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":151,"title":["An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome"],"prefix":"10.1371","volume":"8","author":[{"given":"Iftikhar","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben de Lacy","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman M.","family":"Ratcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris S.","family":"Probert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.47.suppl_2.ii1","article-title":"British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome","volume":"47","author":"J Jones","year":"2000","journal-title":"GUT"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.2006.117598","article-title":"Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence","volume":"56","author":"JG Williams","year":"2007","journal-title":"GUT"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0016-5085(90)91023-Y","article-title":"Epidemiology of irritable bowel syndrome in the United States","volume":"99","author":"RS Sandler","year":"1990","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2982.2006.00875.x","article-title":"Mechanisms of hypersensitivity in IBS and functional disorders","volume":"19","author":"F Azpiroz","year":"2007","journal-title":"Neurogastroenterol Motill"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1053\/j.gastro.2005.11.060","article-title":"Fundamentals of Neurogastroenterology: Basic Science","volume":"130(5)","author":"D Grundy","year":"2006","journal-title":"Gastroenterology"},{"key":"ref6","first-page":"55","article-title":"Irritable bowel syndrome: a model of the brain-gut interactions","volume":"10(4)","author":"A Mulak","year":"2004","journal-title":"Med Sci Monit"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s10620-009-0934-x","article-title":"A molecular analysis of fecal and mucosal bacterial community in irritable bowel syndrome","volume":"5(2)","author":"C Codling","year":"2010","journal-title":"Digestive disease and sciences"},{"key":"ref8","first-page":"580","article-title":"A prospective assessment of bowel habit in irritable bowel syndrome in women: Defining an alternator","volume":"28","author":"DA Drossman","year":"2005"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bmj.2.6138.653","article-title":"Towards positive diagnosis of the irritable bowel syndrome","volume":"2","author":"AP Manning","year":"1978","journal-title":"Br Med J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ajg.2010.56","article-title":"Validation of symptom-based diagnostic criteria for irritable bowel syndrome: A critical review","volume":"105","author":"WE Whitehead","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1443-9573.2006.00265.x","article-title":"Rome III; The new criteria","volume":"7","author":"AD Douglas","year":"2006","journal-title":"Chinese J of Digestive Dis"},{"key":"ref12","unstructured":"Eamonn MMQ (2005) Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases? Chinese J of Digestive Dis. 122\u201332."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.2004.02183.x","article-title":"Review article: epidemiology and quality of life in functional gastrointestinal disorders","volume":"20","author":"L Change","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00019053-200624010-00002","article-title":"Costs of irritable bowel syndrome in the UK and US","volume":"24","author":"S Maxion-Bergemann","year":"2006","journal-title":"Pharmacoeconomics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.dld.2006.05.009","article-title":"Irritable bowel syndrome: The burden and unmet needs in Europe","volume":"38","author":"EMM Quigley","year":"2006","journal-title":"Digestive and Liver Disease"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1053\/gast.2002.34755","article-title":"Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease","volume":"123","author":"JA Tibble","year":"2002","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ibd.20275","article-title":"Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies","volume":"14","author":"AM Schoepfer","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1515\/CCLM.2008.246","article-title":"Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome","volume":"46","author":"CM Otten","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"ref19","first-page":"117","article-title":"Faecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome","volume":"51","author":"H Silberer","year":"2005","journal-title":"Clin Lab"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1088\/1752-7155\/2\/3\/037023","article-title":"An analysis of volatiles in the headspace of the feces of neonates","volume":"2","author":"B De Lacy Costello","year":"2008","journal-title":"J Breath Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/gut.53.1.58","article-title":"A novel method for rapidly diagnosing the causes of diarrhoea","volume":"53","author":"CSJ Probert","year":"2004","journal-title":"GUT"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e18471","DOI":"10.1371\/journal.pone.0018471","article-title":"Solid-phase microextraction and the human fecal VOC metabolome","volume":"6(4)","author":"E Dixon","year":"2011","journal-title":"PLoS ONE"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/mnfr.201000442","article-title":"Impact of the synbiotic combination of Lactulose casei shirota and oligofructose-enriched inulin on the fecal volatile metabolite profile in the healthy subjects","volume":"55(5)","author":"V De Preter","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1096\/fj.06-6927com","article-title":"Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease","volume":"21","author":"CE Garner","year":"2007","journal-title":"FASEB J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MPG.0b013e3181a3bfbc","article-title":"Analysis of fecal volatile organic compounds in preterm infants who develop necrotising enterocolitis: a pilot study","volume":"49","author":"CE Garner","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.trstmh.2009.02.004","article-title":"A pilot study of fecal VOC in feces from cholera patients in Bangladesh to determine their utility in disease diagnosis","volume":"103","author":"CE Garner","year":"2009","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn's disease activity","volume":"315","author":"RF Harvey","year":"1980","journal-title":"The Lancet"},{"key":"ref28","first-page":"1759","article-title":"Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts' classification","volume":"90(10)","author":"M Seo","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"ref29","unstructured":"Ahmed I (2011) Diagnostic potential of fecal volatile organic compounds in inflammatory bowel disease. Thesis (Chapter 3, Method Development) University of Bristol."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.2517-6161.1977.tb01603.x","article-title":"An asymptotic equivalence of choice of model by cross-validation and Akaike's criterion","volume":"39","author":"M Stone","year":"1977","journal-title":"Journal of the Royal Statistical Society Series B (Methodological)"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.3748\/wjg.15.6068","article-title":"Elevated pro-inflammatory and Lipotoxic mucosal lipids chracterise irritable bowel syndrome","volume":"14","author":"K Kajander","year":"2009","journal-title":"World J Gasteroenterol"},{"key":"ref32","first-page":"512","article-title":"Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome","volume":"22(5)","author":"C Tana","year":"2010","journal-title":"Neurogastroenterology & Motility"},{"key":"ref33","first-page":"212","article-title":"Degradation of organic acids by dairy lactic acid bacteria","volume":"135(3)","author":"IG Hegazi FZ Abo-EInaga","year":"1980","journal-title":"Zentralbl Bakteriol Naturwiss"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/anae.1997.0129","article-title":"Comparison of batch culture growth and fermentation of a poultry veillonella isolate and selected veillonella species grown in a defined medium","volume":"3","author":"JA Durant","year":"1997","journal-title":"Anaerobe"},{"key":"ref35","first-page":"1","article-title":"High-level dietary fibre up-regulates colonic fermentation and relative abundance of saccharolytic bacteria within the human faecal microbiota in vitro","author":"Q Shen","year":"2011","journal-title":"European Journal of Nutrition"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1136\/gut.2004.041632","article-title":"Inhibitory actions of a high fibre diet on intestinal gas transit in healthy volunteers","volume":"53(11)","author":"S Gonlachanvit","year":"2004","journal-title":"GUT"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2036.2007.03544.x","article-title":"Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae","volume":"27","author":"M Elia","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1365-2036.1997.00250.x","article-title":"Absence of gaseous symptoms during ingestion of commercial fibre preparations","volume":"11","author":"L Zumarraga","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-277X.2011.01162.x","article-title":"Comparison of symptom response following advice for a diet low in fermentable (FODMAP) carbohydrates versus standard dietary advice in patients with IBS","volume":"24(5)","author":"HM Staudacher","year":"2011","journal-title":"J Hum Nutr Diet"},{"key":"ref40","first-page":"1366","article-title":"Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in IBS","volume":"25(8)","author":"DK Ong","journal-title":"J Gastroenterol Hepatol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-230X-10-23","article-title":"Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?","volume":"10","author":"S Reddymasu","year":"2010","journal-title":"BMC Gastroenterology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1023\/A:1021738515885","article-title":"Methane production during lactulose breath test is associated with gastrointestinal disease presentation","volume":"48","author":"M Pimentel","year":"2003","journal-title":"Dig Dis Sci"},{"key":"ref43","first-page":"157","article-title":"Reassessment of the role of methane production between irritable bowel syndrome and functional constipation","volume":"21","author":"M Furnari","year":"2012","journal-title":"J Gastrointestin Liver Dis"},{"issue":"42(1)","key":"ref44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02235186","article-title":"Breath alkanes determination in ulcerative colitis and Crohn's disease","volume":"Rectum","author":"MA Pelli","year":"1999","journal-title":"Dis Colon"},{"key":"ref45","first-page":"2007","article-title":"Can calprotectin predict relapse risk in inflammatory bowel disease?","volume":"Gastroenterol103","author":"R D'Inc\u00e0","year":"2008","journal-title":"Am J"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00054725-200606000-00013","article-title":"Role of faecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease","volume":"12","author":"MR Konikoff","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.dld.2008.05.008","article-title":"Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease","volume":"41","author":"JP Gisbert","year":"2009","journal-title":"Digestive and Liver Disease"},{"key":"ref48","first-page":"41","article-title":"Diagnostic value of fecal calprotectin in predicting an abnormal colonoscopy","volume":"127","author":"V Garcia Sanchez","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.crohns.2009.09.008","article-title":"Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?","volume":"4","author":"V Garc\u00eda-S\u00e1nchez","year":"2010","journal-title":"J Crohns Colitis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/gut.2004.043406","article-title":"Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease","volume":"54(3)","author":"F Costa","year":"2005","journal-title":"GUT"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.gtc.2012.01.007","article-title":"Faecal markers: calprotectin and lactoferrin","volume":"41","author":"BP Abraham","year":"2012","journal-title":"Gastroenterol Clin North Am"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/14622416.7.7.1055","article-title":"Metabolic profiling technologies for biomarker discovery in biomedicine and drug development","volume":"7","author":"G Schlotterbeck","year":"2006","journal-title":"Pharmacogenomics"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/rcm.3466","article-title":"Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography\/mass spectrometry","volume":"22","author":"R Xue","year":"2008","journal-title":"Rapid Commun Mass Spectrom"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1378\/chest.123.6.2115","article-title":"Detection of lung cancer with volatile markers in the breath","volume":"123","author":"M Phillips","year":"2003","journal-title":"Chest"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1524-4741.2003.09309.x","article-title":"Volatile markers of breast cancer in the breath","volume":"9","author":"M Phillips","year":"2003","journal-title":"The Breast Journal"},{"key":"ref56","first-page":"337","article-title":"Volatile organic compounds in the diagnosis of gastrointestinal and liver disease. J Gastrointestin Liver Dis","volume":"18(3)","author":"I Probert CS. Ahmed","year":"2009"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/14737159.6.4.575","article-title":"Metabolomic approaches to phenotype characterization and application to complex disease","volume":"6","author":"M Oresic","year":"2006","journal-title":"Expert review of molecular diagnostics"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0058204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T16:46:48Z","timestamp":1588956408000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0058204"}},"subtitle":[],"editor":[{"given":"David L.","family":"Boone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,13]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0058204","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,13]]}}}